Onabotulinum toxin injection and headaches

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Onabotulinum toxin A (botulinum toxin type A, Botox®) is a focally acting neurotoxin that inhibits the release of neurotransmitters from presynaptic nerves. Preclinical evidence has shown that onabotulinum toxin A has anti-inflammation and antinociceptive properties. Onabotulinum toxin A is a safe and effective treatment for chronic migraine. Seven botulinum toxin serotypes are produced by Clostridium botulinum (i.e., A, B, C, D, E, F, and G). Botulinum toxins consist of a heavy chain of 100 kDa and a light chain of 50 kDa linked by a single disulfide bond and are synthesized as a relatively inactive single-chain polypeptide.

Cite

CITATION STYLE

APA

Blumenfeld, A., Silberstein, S. D., & Oshinsky, M. L. (2014). Onabotulinum toxin injection and headaches. In Interventional Management of Head and Face Pain: Nerve Blocks and Beyond (pp. 103–110). Springer New York. https://doi.org/10.1007/978-1-4614-8951-1_15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free